Burns T W, Langley P E
J Cyclic Nucleotide Res. 1975;1(5):321-8.
The effects of the mixed agonist epinephrine and the beta agonist isoproterenol, each alone and in combination with the alpha adrenergic blocker phentolamine and the beta blocker propranolol on the adenylate cyclase activity of human adipocyte membrane fragments were determined in a calcium free buffer. Neither phentolamine (10 muM) nor propranolol (32 muM) affected basal adenylate cyclase activity. Epinephrine (10 muM) stimulated adenylate cyclase activity and this effect was slightly enhanced by phentolamine. The combination of epinephrine plus propranolol depressed adenylate cyclase below the basal level. Isoproterenol (10 muM) markedly stimulated adenylate cyclase; the addition of phentolamine caused an equivocal further increase while the addition of propranolol depressed adenylate cyclase activity to, but not below, the basal level. These findings are consistent with the hypothesis that human adipocytes have both alpha and beta adrenergic receptors and that these receptors are associated with the cell membrane adenylate cyclase system.
在无钙缓冲液中测定了混合激动剂肾上腺素和β激动剂异丙肾上腺素单独以及与α肾上腺素能阻滞剂酚妥拉明和β阻滞剂普萘洛尔联合使用时,对人脂肪细胞膜片段腺苷酸环化酶活性的影响。酚妥拉明(10μM)和普萘洛尔(32μM)均不影响基础腺苷酸环化酶活性。肾上腺素(10μM)刺激腺苷酸环化酶活性,酚妥拉明可使其作用略有增强。肾上腺素加普萘洛尔的组合使腺苷酸环化酶活性降至基础水平以下。异丙肾上腺素(10μM)显著刺激腺苷酸环化酶;加入酚妥拉明导致进一步增加,但不明确,而加入普萘洛尔则使腺苷酸环化酶活性降至基础水平,但不低于基础水平。这些发现与以下假设一致,即人脂肪细胞同时具有α和β肾上腺素能受体,且这些受体与细胞膜腺苷酸环化酶系统相关。